In this May edition of our Dynamic Top Pick List we replace Arcadis by Fugro. Arcadis continues to deliver consistently on its promises and is working hard to realise its 2026 margin targets via cross selling, leveraging its global engineering platform and numerous self-help measures. In spite of this we remove Arcadis from our Dynamic Top Pick List as the recent & strong share price performance leaves little room for further short term triggers As a service provider to the energy industry, Fu...
argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024 May 2, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, May 9, 2024 at 2:30 PM CET (8:30 AM ET) to discuss its first quarter 2024 financial results and provide a business update. A webcast of the live call may be accessed on the Investors section of the argenx website at . A replay of the ...
Euronext upgraded to ‘BBB+, Positive Outlook‘ by S&P Contacts Media Contact Investor Relations Amsterdam Brussels 27 Dublin 13 Lisbon 4 Milan 12 Oslo Paris 45 Euronext upgraded to ‘BBB+, Positive Outlook‘ by S&P Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 30 April 2024 – Euronext, the leading pan-European market infrastructure, today welcomes the decision of S&P to upgrade Euronext from ‘BBB+, Stable Outlook’ to ‘BBB+, Positive Outlook’. S&P decision reflects the approaching completion of the integration of the Borsa Italia...
Our trip to South Korea and China revealed Chinese shipbuilders are seeking growth to take on Korea’s established yards who are facing constraints. An eagerness to add capacity is one of our takeaways, as well as a gloomy outlook for Chinese real estate, which in our view should inevitably weigh on dry bulk demand.
Progress on ABN AMRO share buyback programme 19 April – 25 April 2024 Progress on ABN AMRO share buyback programme 19 April – 25 April 2024 ABN AMRO reports the transaction details related to its EUR 500 million share buyback programme announced on 14 February 2024. During the week of 19 April 2024 up to and including 25 April 2024 a total of 3,000,000 shares and depositary receipts were repurchased at an average price of €15.72 for a total amount of €47,170,980. For detailed information on the daily repurchased shares and depositary receipts, individual share purchase tra...
Progress on ABN AMRO share buyback programme 12 April – 18 April 2024 Progress on ABN AMRO share buyback programme 12 April – 18 April 2024 ABN AMRO reports the transaction details related to its EUR 500 million share buyback programme announced on 14 February 2024. During the week of 12 April 2024 up to and including 18 April 2024 a total of 3,000,000 shares and depositary receipts were repurchased at an average price of €15.74 for a total amount of €47,215,740.00. For detailed information on the daily repurchased shares and depositary receipts, individual share purchase transactions an...
argenx announced additional detail on its Phase 3 ADHERE data with Vyvgart Hytrulo, showcasing its speed of onset and depth of response. We believe that Vyvgart Hytrulo is well positioned vs. the approved standard-of-care IVIg/SCIg across patient types, and look forward to the FDA decision (PDUFA: June 21, 2024). € 435 TP and Buy rating reiterated.
argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease ADHERE data show VYVGART® Hytrulo has potential to be first advancement for CIDP patients in 30 years Real-world data demonstrate gMG patients able to significantly reduce steroid use over first six months of initiating VYVGART® treatment April 16, 2024 – 7:00am CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, ...
• ARGX shared additional results from the ADHERE (open-label) study and real-world data from gMG patients at the AAN Annual Meeting. • Data indicates rapid, deep, and clinically meaningful/sustained improvements in CIDP & with ability to reduce steroid burden (gMG). • We expect a positive outcome of the decision on regulatory approval for CDP by June 21 (85% LoA, +4% impact on TP) and currently project low double-digit million in sales this year. This might seem rather conservative (vs. gMG init...
Progress on ABN AMRO share buyback programme 5 April – 11 April 2024 Progress on ABN AMRO share buyback programme 5 April – 11 April 2024 ABN AMRO reports the transaction details related to its EUR 500 million share buyback programme announced on 14 February 2024. During the week of 5 April 2024 up to and including 11 April 2024 a total of 3,000,000 shares and depositary receipts were repurchased at an average price of €16.37 for a total amount of €49,112,760. For detailed information on the daily repurchased shares and depositary receipts, individual share purchase transactions and week...
Euronext announces volumes for March 2024 Contacts Media Contact Investor Relations Amsterdam Brussels 17 Dublin 13 Lisbon 97 Milan 56 Oslo Paris 45 Euronext announces volumes for March 2024 Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 8 April 2024 – Euronext, the leading pan-European market infrastructure, today announced trading volumes for March 2024. Monthly and historical volume tables are available at this address: CONTACTS MEDIA – Europe A...
Progress on ABN AMRO share buyback programme 29 March – 4 April 2024 Progress on ABN AMRO share buyback programme 29 March – 4 April 2024 ABN AMRO reports the transaction details related to its EUR 500 million share buyback programme announced on 14 February 2024. During the week of 29 March 2024 up to and including 4 April 2024 a total of 1,800,000 shares and depositary receipts were repurchased at an average price of €16.14 for a total amount of €29,053,980.00. For detailed information on the daily repurchased shares and depositary receipts, individual share purchase transactions and w...
We continue our KBC Securities Dynamic Top Pick List with a 50/50 cyclical/defensive selection, but with a focus on value stocks that have been left behind. Defensive segment like holdings are overweight. However, in the Benelux we have a selection of cyclical industrials at cheap valuations that have often underperformed the market. We favour Benelux value stocks as even a mild recession typically hits growth stocks proportionally harder. We notice that some stocks have been hit hard by minor s...
Progress on ABN AMRO share buyback programme 22 – 28 March 2024 Progress on ABN AMRO share buyback programme 22 – 28 March 2024 ABN AMRO reports the transaction details related to its EUR 500 million share buyback programme announced on 14 February 2024. During the week of 22 March 2024 up to and including 28 March 2024 a total of 3,000,000 shares and depositary receipts were repurchased at an average price of €15.47 for a total amount of €46,409,760.00. For detailed information on the daily repurchased shares and depositary receipts, individual share purchase transactions and weekly rep...
Euronext to acquire Global Rate Set Systems to strengthen its index franchise Contacts Media Contact Investor Relations Amsterdam Brussels 17 Dublin 13 Lisbon 4 Milan 12 Oslo Paris 45 Euronext to acquire Global Rate Set Systems to strengthen its index franchise Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 29 March 2024 – Euronext, the leading pan-European market infrastructure, today announces that it has entered into an agreement to acquire 75% of the share capital of Global Rate Set Systems (GRSS), a leading provider of ser...
Euronext publishes its 2023 Universal Registration Document Contacts MediaContact Investor RelationsAmsterdam Brussels 17Dublin 13Lisbon 4 Milan 12Oslo Paris 45 Euronext publishes its 2023 Universal Registration Document Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 28 March 2024 – Euronext, the leading pan-European market infrastructure, today announces that it has filed its 2023 Universal Registration Document, prepared in ESEF format (European Single Electronic Format), including the 2023 Annual Financial Statements and Directors’ Report to the Stichting Autoriteit...
Convening of the Annual General Meeting of Euronext N.V. Contacts MediaContact Investor RelationsAmsterdam Brussels 17Dublin 13Lisbon 4 Milan 12Oslo Paris 45 Convening of the Annual General Meeting of Euronext N.V. Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 28 March 2024 – Euronext today announced that the Annual General Meeting (“AGM”) will take place on Wednesday 15 May 2024 at 10.30 CEST at Beursplein 5, 1012 JW Amsterdam, The Netherlands. The agenda for the meeting is as follows: Opening Presentation of the Chief Executive Officer (discussion item)Annual rep...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.